Attached files
| file | filename |
|---|---|
| EX-31.6 - EXHIBIT 31.6 - Sorrento Therapeutics, Inc. | v465541_ex31-6.htm |
| EX-10.35 - EXHIBIT 10.35 - Sorrento Therapeutics, Inc. | v465541_ex10-35.htm |
| EX-10.34 - EXHIBIT 10.34 - Sorrento Therapeutics, Inc. | v465541_ex10-34.htm |
| EX-10.32 - EXHIBIT 10.32 - Sorrento Therapeutics, Inc. | v465541_ex10-32.htm |
| EX-10.31 - EXHIBIT 10.31 - Sorrento Therapeutics, Inc. | v465541_ex10-31.htm |
| 10-K/A - FORM 10-K/A - Sorrento Therapeutics, Inc. | v465541_10ka.htm |
Exhibit 31.5
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Henry Ji, certify that:
| 1. | I have reviewed this Amendment No. 2 to Annual Report on Form 10-K/A of Sorrento Therapeutics, Inc.; and |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
| Date: April 28, 2017 | By: | /s/ Henry Ji |
| Henry Ji | ||
| President and Chief Executive Officer | ||
| (Principal Executive Officer) |